Open AccessISSUES OF MEDICAL CARE FOR LOWER JAW FRACTURES IN OLDER PERSONS
Author(s) -
А. С. Панкратов,
A.V. Karalkin,
Zauri P. Gotsiridze
Publication year - 2019
Publication title -
rossijskij stomatologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2413-2934
pISSN - 1728-2802
DOI - 10.18821/1728-2802-2019-23-3-4-165-172
Subject(s) - medicine , rehabilitation , clinical trial , randomized controlled trial , medline , population , quality of life (healthcare) , dentistry , physical therapy , surgery , environmental health , nursing , pathology , political science , law
At present, there is an increase in the number and proportion of older persons. Accordingly, the requirements to ensure the necessary quality of life of this category of population are increasing. This applies, inter alia, to the issues of their rehabilitation after various diseases and injuries. Among the injuries of the bones of the facial skeleton, the most common type are fractures of the lower jaw. The purpose of this work is to analyze the prevalence, clinical features of mandibular fractures in patients of the older age group and the effectiveness of existing methods of their treatment, according to modern literature data. RSCI, PubMed, Medline databases for the period 1960 - 2019 were used to compile the review. Results. Data from 687 literary sources were used in the preparation of this review. Their analysis shows that older patients represent a stable and statistically significant group, in the General structure of victims with mandibular fractures, and having a number of clinical features, as a result of which conventional methods of treatment are often ineffective. The most common concepts of medical care for this category of patients are characterized. Conclusion. To date, there are no reliable randomized clinical trials based on sufficient statistically material that allows to substantiate the advantages of a particular method of treatment of older patients with mandibular fractures at the evidence level, which requires the continuation of the relevant multicenter clinical studies.